|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
Journal Archive
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gynecologic cancer
Uptake of Family-Specific
Mutation
Genetic Testing Among Relatives of Patients with Ovarian Cancer with
BRCA1
or
BRCA2
Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.
2021;53(1):207-211. Published online August 11, 2020 DOI:
https://doi.org/10.4143/crt.2020.364
Lung cancer
A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating
EGFR
Mutation
s in Circulating Tumor DNA: LiquidLung-O-Cohort 1
Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
Cancer Res Treat.
2021;53(1):93-103. Published online September 21, 2020 DOI:
https://doi.org/10.4143/crt.2020.459
Gynecologic cancer
Germline and Somatic
BRCA1/2
Gene
Mutation
al Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.
2020;52(4):1229-1241. Published online July 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.557
Gastrointestinal cancer
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or
POLE
-Mutated Metastatic or Unresectable Colorectal Cancer
Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
Cancer Res Treat.
2020;52(4):1135-1144. Published online April 24, 2020 DOI:
https://doi.org/10.4143/crt.2020.218
Cited By 5
Lung cancer
Genetic Alterations in Preinvasive Lung Synchronous Lesions
Soyeon Ahn, Jisun Lim, Soo Young Park, Hyojin Kim, Hyun Jung Kwon, Yeon Bi Han, Choon-Taek Lee, Sukki Cho, Jin-Haeng Chung
Cancer Res Treat.
2020;52(4):1120-1134. Published online June 5, 2020 DOI:
https://doi.org/10.4143/crt.2020.307
Detection of Germline
Mutation
s in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat.
2020;52(3):697-713. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.559
Cited By 3
PIK3CA
H1047R
Mutation
Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.
2020;52(3):689-696. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.497
Cited By 2
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with
HER2
Alterations in Korea
Kangkook Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2020;52(1):292-300. Published online July 26, 2019 DOI:
https://doi.org/10.4143/crt.2019.186
Cited By 2
Active and Passive Smoking,
BRAF
V600E
Mutation
Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
Cancer Res Treat.
2019;51(4):1392-1399. Published online February 20, 2019 DOI:
https://doi.org/10.4143/crt.2018.612
Cited By 1
Inherited
NBN
Mutation
s and Prostate Cancer Risk and Survival
Bogna Rusak, Wojciech Kluźniak, Dominika Wokołorczykv, Klaudia Stempa, Aniruddh Kashyap, Jacek Gronwald, Tomasz Huzarski, Tadeusz Dębniak, Anna Jakubowska, Bartłomiej Masojć, Mohammad R. Akbari, Steven A. Narodv, Jan Lubiński, Cezary Cybulski, The Polish Hereditary Prostate Cancer Consortium
Cancer Res Treat.
2019;51(3):1180-1187. Published online December 13, 2018 DOI:
https://doi.org/10.4143/crt.2018.532
Cited By 6
Prevalence of
PALB2
Germline
Mutation
s in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat.
2019;51(3):992-1000. Published online October 11, 2018 DOI:
https://doi.org/10.4143/crt.2018.356
Cited By 1
Clinical and Genetic Characteristics of
BRCA1/2
Mutation
in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Res Treat.
2019;51(3):941-950. Published online October 8, 2018 DOI:
https://doi.org/10.4143/crt.2018.312
Cited By 3
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, Yoon Hee Choi, Hye Ryun Kim, Hoon-Gu Kim, Heui June Ahn, Ha Yeon Lee, Hwan Jung Yun, Jin-Hyoung Kang, Jaeheon Jeong, Moon Young Choi, Sin-Ho Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2019;51(2):718-726. Published online September 3, 2018 DOI:
https://doi.org/10.4143/crt.2018.324
Cited By 2
Clinical Outcomes of
EGFR
Exon 20 Insertion
Mutation
s in Advanced Non-small Cell Lung Cancer in Korea
Seonggyu Byeon, Youjin Kim, Sung Won Lim, Jang Ho Cho, Sehoon Park, Jiyun Lee, Jong-Mu Sun, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2019;51(2):623-631. Published online July 23, 2018 DOI:
https://doi.org/10.4143/crt.2018.151
Cited By 10
EGFR
Mutation
Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Song Ee Park, Jae Myoung Noh, You Jin Kim, Han Sang Lee, Jang Ho Cho, Sung Won Lim, Yong Chan Ahn, Hongryull Pyo, Yoon-La Choi, Joungho Han, Jong-Mu Sun, Se Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.
2019;51(2):493-501. Published online June 18, 2018 DOI:
https://doi.org/10.4143/crt.2018.125
Cited By 6
Founder
Mutation
s for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland
Tadeusz Dębniak, Rodney J Scott, Rodney A Lea, Bohdan Górski, Bartłomiej Masojć, Cezary Cybulski, Andrzej Kram, Romuald Maleszka, Tomasz Gromowski, Katarzyna Paszkowska-Szczur, Aniruddh Kashyap, Marcin R. Lener, Karolina Malińska, Emilia Rogoża, Dawid Murawa, Helena Rudnicka, Jakub Deptuła, Jan Lubiński
Cancer Res Treat.
2019;51(1):337-344. Published online May 14, 2018 DOI:
https://doi.org/10.4143/crt.2018.157
Cited By 2
Impact of Pulmonary Tuberculosis on the
EGFR
Mutation
al Status and Clinical Outcome in Patients with Lung Adenocarcinoma
In Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee
Cancer Res Treat.
2019;51(1):158-168. Published online April 2, 2018 DOI:
https://doi.org/10.4143/crt.2018.084
Cited By 2
The Association of Acquired T790M
Mutation
with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Kun-Chieh Chen, Chia-Hung Hsu, Kang-Yi Su, Jeremy J. W. Chen, Huei-Wen Chen, Sung-Liang Yu, Tsung-Ying Yang, Gee-Chen Chang
Cancer Res Treat.
2018;50(4):1294-1303. Published online January 4, 2018 DOI:
https://doi.org/10.4143/crt.2017.512
Cited By 15
Detection of Germline
Mutation
s in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond
BRCA1/2
Kyung Jin Eoh, Ji Eun Kim, Hyung Seok Park, Seung-Tae Lee, Ji Soo Park, Jung Woo Han, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Jae Hoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2018;50(3):917-925. Published online September 27, 2017 DOI:
https://doi.org/10.4143/crt.2017.220
Cited By 14
Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
Tae Min Kim, Keun-Wook Lee, Do-Youn Oh, Jong-Seok Lee, Seock-Ah Im, Dong-Wan Kim, Sae-Won Han, Yu Jung Kim, Tae-You Kim, Jee Hyun Kim, Hyesun Han, Woo Ho Kim, Yung-Jue Bang
Cancer Res Treat.
2018;50(3):835-842. Published online August 29, 2017 DOI:
https://doi.org/10.4143/crt.2017.303
Cited By 24
Prevalence of
Mutation
s in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
Mi-Sook Lee, Eun Ah Jung, Sung Bin An, Yu Jin Kim, Doo-Yi Oh, Ji-Young Song, Sang-Won Um, Joungho Han, Yoon-La Choi
Cancer Res Treat.
2017;49(4):1065-1076. Published online January 25, 2017 DOI:
https://doi.org/10.4143/crt.2016.347
Cited By 6
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han
Cancer Res Treat.
2017;49(4):1001-1011. Published online January 13, 2017 DOI:
https://doi.org/10.4143/crt.2016.546
Cited By 16
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to
EGFR
Mutation
Status
Youngjoo Lee, Ji-Youn Han, Sung Ho Moon, Byung-Ho Nam, Kun Young Lim, Geon Kook Lee, Heung Tae Kim, Tak Yun, Hye Jin An, Jin Soo Lee
Cancer Res Treat.
2017;49(4):981-989. Published online January 6, 2017 DOI:
https://doi.org/10.4143/crt.2016.522
Cited By 4
The Prevalence of Founder
Mutation
s among Individuals from Families with Familial Pancreatic Cancer Syndrome
Marcin R. Lener, Aniruddh Kashyap, Wojciech Kluźniak, Cezary Cybulski, Agnieszka Soluch, Sandra Pietrzak, Tomasz Huzarski, Jacek Gronwald, Jan Lubiński
Cancer Res Treat.
2017;49(2):430-436. Published online July 28, 2016 DOI:
https://doi.org/10.4143/crt.2016.217
Cited By 9
Can Serum be Used for Analyzing the
KRAS
Mutation
Status in Patients with Advanced Colorectal Cancer?
Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim
Cancer Res Treat.
2015;47(4):796-803. Published online January 30, 2015 DOI:
https://doi.org/10.4143/crt.2014.106
Cited By 4
Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of
EGFR
Gene
Mutation
in Patients with Non-small Cell Lung Cancer
Seong-Hoon Yoon, Yoo-Duk Choi, In-Jae Oh, Kyu-Sik Kim, Hayoung Choi, Jinsun Chang, Hong-Joon Shin, Cheol-Kyu Park, Young-Chul Kim
Cancer Res Treat.
2015;47(4):661-669. Published online February 23, 2015 DOI:
https://doi.org/10.4143/crt.2014.282
Cited By 18
Identification of
EGFR
Mutation
s by Immunohistochemistry with
EGFR
Mutation
–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
Chi Hong Kim, Seung Hoon Kim, Sonya Youngju Park, Jinyoung Yoo, Sung Kyoung Kim, Hoon Kyo Kim
Cancer Res Treat.
2015;47(4):653-660. Published online January 30, 2015 DOI:
https://doi.org/10.4143/crt.2014.118
Cited By 11
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo
Cancer Res Treat.
2013;45(3):178-185. Published online September 30, 2013 DOI:
https://doi.org/10.4143/crt.2013.45.3.178
Cited By 8
Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis
Dong Soo Lee, Jin Hyoung Kang, Chang Geol Lee, Seoung Jun Kim, Young Jin Choi, Kyo Young Lee, Yeon Sil Kim
Cancer Res Treat.
2013;45(2):95-102. Published online June 30, 2013 DOI:
https://doi.org/10.4143/crt.2013.45.2.95
Cited By 15
Present Status and Problems on Molecular Targeted Therapy of Cancer
Nagahiro Saijo
Cancer Res Treat.
2012;44(1):1-10. Published online March 31, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.1.1
Cited By 18
1
2